surpass cvot tirzepatide results CV Safety Comparable to Dulaglutide in SURPASS-CVOT | Paramesh Shamanna posted on the topic SURPASS-CVOT: Tirzepatide Bests Dulaglutide for

Its been such an easy experience

This guide will break down the essential details to help you understand what makes each one unique

1 The findings were significant: Those not taking GLP-1 medications showed significantly more MS disease progression Higher risk of brainstem dysfunction (4.36% risk difference) Higher risk of cerebellar dysfunction (4.54% risk difference) Higher risk of bowel and bladder dysfunction (4.98% risk difference) Research from Johns Hopkins University found that GLP-1 receptor agonists delayed disease onset and reduced severity in animal models of MS

The broader comparison between peptides versus other compound classes applies here

First, you must be prescribed Mounjaro for an FDA-approved use, consistent with the medications labeling (e.g